FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214766289> ?p ?o ?g. }

• W4214766289 endingPage "2771.e3" @default.
• W4214766289 startingPage "2763" @default.
• W4214766289 abstract "Recommended surveillance intervals after complete eradication of intestinal metaplasia (CE-IM) after endoscopic eradication therapy (EET) are largely not evidence-based. Using recurrence rates in a multicenter international Barrett's esophagus (BE) CE-IM cohort, we aimed to generate optimal intervals for surveillance.Patients with dysplastic BE undergoing EET and achieving CE-IM from prospectively maintained databases at 5 tertiary-care centers in the United States and the United Kingdom were included. The cumulative incidence of recurrence was estimated, accounting for the unknown date of actual recurrence that lies between the dates of current and previous endoscopy. This cumulative incidence of recurrence subsequently was used to estimate the proportion of patients with undetected recurrence for various surveillance intervals over 5 years. Intervals were selected that minimized recurrences remaining undetected for more than 6 months. Actual patterns of post-CE-IM follow-up evaluation are described.A total of 498 patients (with baseline low-grade dysplasia, 115 patients; high-grade dysplasia [HGD], 288 patients; and intramucosal adenocarcinoma [IMCa], 95 patients) were included. Any recurrence occurred in 27.1% and dysplastic recurrence occurred in 8.4% over a median of 2.6 years of follow-up evaluation. For pre-ablation HGD/IMCa, intervals of 6, 12, 18, and 24 months, and then annually, resulted in no patients with dysplastic recurrence undetected for more than 6 months, comparable with current guideline recommendations despite a 33% reduction in the number of surveillance endoscopies. For pre-ablation low-grade dysplasia, intervals of 1, 2, and 4 years balanced endoscopic burden and undetected recurrence risk.Lengthening post-CE-IM surveillance intervals would reduce the endoscopic burden after CE-IM with comparable rates of recurrent HGD/IMCa. Future guidelines should consider reduced surveillance frequency." @default.
• W4214766289 created "2022-03-02" @default.
• W4214766289 creator A5000689518 @default.
• W4214766289 creator A5001288732 @default.
• W4214766289 creator A5004136681 @default.
• W4214766289 creator A5006986778 @default.
• W4214766289 creator A5007801524 @default.
• W4214766289 creator A5017471271 @default.
• W4214766289 creator A5017993142 @default.
• W4214766289 creator A5030507745 @default.
• W4214766289 creator A5030588426 @default.
• W4214766289 creator A5031027678 @default.
• W4214766289 creator A5041055206 @default.
• W4214766289 creator A5060644314 @default.
• W4214766289 creator A5065354370 @default.
• W4214766289 creator A5074839138 @default.
• W4214766289 creator A5078986341 @default.
• W4214766289 creator A5080271414 @default.
• W4214766289 creator A5080531404 @default.
• W4214766289 creator A5081620816 @default.
• W4214766289 creator A5089888467 @default.
• W4214766289 date "2022-12-01" @default.
• W4214766289 modified "2023-10-11" @default.
• W4214766289 title "Optimized Surveillance Intervals Following Endoscopic Eradication of Dysplastic Barrett’s Esophagus: An International Cohort Study" @default.
• W4214766289 cites W1998897263 @default.
• W4214766289 cites W2023770280 @default.
• W4214766289 cites W2024455739 @default.
• W4214766289 cites W2025343608 @default.
• W4214766289 cites W2125681184 @default.
• W4214766289 cites W2137173028 @default.
• W4214766289 cites W2161840081 @default.
• W4214766289 cites W2186005749 @default.
• W4214766289 cites W2187093113 @default.
• W4214766289 cites W2328622617 @default.
• W4214766289 cites W2621220329 @default.
• W4214766289 cites W2621353671 @default.
• W4214766289 cites W2787274608 @default.
• W4214766289 cites W2797107997 @default.
• W4214766289 cites W2808045510 @default.
• W4214766289 cites W2808090351 @default.
• W4214766289 cites W2908706739 @default.
• W4214766289 cites W2969502958 @default.
• W4214766289 cites W3001033850 @default.
• W4214766289 cites W3012658879 @default.
• W4214766289 cites W3096065979 @default.
• W4214766289 cites W3137697691 @default.
• W4214766289 doi "https://doi.org/10.1016/j.cgh.2022.02.043" @default.
• W4214766289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35245702" @default.
• W4214766289 hasPublicationYear "2022" @default.
• W4214766289 type Work @default.
• W4214766289 citedByCount "3" @default.
• W4214766289 countsByYear W42147662892022 @default.
• W4214766289 countsByYear W42147662892023 @default.
• W4214766289 crossrefType "journal-article" @default.
• W4214766289 hasAuthorship W4214766289A5000689518 @default.
• W4214766289 hasAuthorship W4214766289A5001288732 @default.
• W4214766289 hasAuthorship W4214766289A5004136681 @default.
• W4214766289 hasAuthorship W4214766289A5006986778 @default.
• W4214766289 hasAuthorship W4214766289A5007801524 @default.
• W4214766289 hasAuthorship W4214766289A5017471271 @default.
• W4214766289 hasAuthorship W4214766289A5017993142 @default.
• W4214766289 hasAuthorship W4214766289A5030507745 @default.
• W4214766289 hasAuthorship W4214766289A5030588426 @default.
• W4214766289 hasAuthorship W4214766289A5031027678 @default.
• W4214766289 hasAuthorship W4214766289A5041055206 @default.
• W4214766289 hasAuthorship W4214766289A5060644314 @default.
• W4214766289 hasAuthorship W4214766289A5065354370 @default.
• W4214766289 hasAuthorship W4214766289A5074839138 @default.
• W4214766289 hasAuthorship W4214766289A5078986341 @default.
• W4214766289 hasAuthorship W4214766289A5080271414 @default.
• W4214766289 hasAuthorship W4214766289A5080531404 @default.
• W4214766289 hasAuthorship W4214766289A5081620816 @default.
• W4214766289 hasAuthorship W4214766289A5089888467 @default.
• W4214766289 hasBestOaLocation W42147662892 @default.
• W4214766289 hasConcept C120665830 @default.
• W4214766289 hasConcept C121332964 @default.
• W4214766289 hasConcept C121608353 @default.
• W4214766289 hasConcept C126322002 @default.
• W4214766289 hasConcept C141071460 @default.
• W4214766289 hasConcept C142724271 @default.
• W4214766289 hasConcept C2775894508 @default.
• W4214766289 hasConcept C2776497702 @default.
• W4214766289 hasConcept C2777819096 @default.
• W4214766289 hasConcept C2778451229 @default.
• W4214766289 hasConcept C2778589982 @default.
• W4214766289 hasConcept C2780182762 @default.
• W4214766289 hasConcept C2781182431 @default.
• W4214766289 hasConcept C61511704 @default.
• W4214766289 hasConcept C71924100 @default.
• W4214766289 hasConcept C72563966 @default.
• W4214766289 hasConcept C88879693 @default.
• W4214766289 hasConceptScore W4214766289C120665830 @default.
• W4214766289 hasConceptScore W4214766289C121332964 @default.
• W4214766289 hasConceptScore W4214766289C121608353 @default.
• W4214766289 hasConceptScore W4214766289C126322002 @default.
• W4214766289 hasConceptScore W4214766289C141071460 @default.
• W4214766289 hasConceptScore W4214766289C142724271 @default.
• W4214766289 hasConceptScore W4214766289C2775894508 @default.

• next